Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea
· Delayed Price · Currency is KRW 5,540.00
-10.00 (-0.18%)
At close: May 30, 2025, 3:30 PM KST
Kwang Dong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 26,029 | 40,481 | 36,966 | 24,174 | 24,019 | 45,370 | Upgrade
|
| Depreciation & Amortization | 14,848 | 14,532 | 12,904 | 14,017 | 14,110 | 19,709 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10,010 | -3,026 | 1,964 | -166.52 | -38.87 | -1,178 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 2,735 | Upgrade
|
| Loss (Gain) From Sale of Investments | -16,115 | -25,399 | -9,412 | 1,932 | 10,232 | -17,536 | Upgrade
|
| Loss (Gain) on Equity Investments | 3,323 | -767.76 | 429.82 | 435.51 | 112.22 | 62.65 | Upgrade
|
| Stock-Based Compensation | 43.1 | - | - | - | 17.59 | 152.06 | Upgrade
|
| Provision & Write-off of Bad Debts | 1,901 | 2,421 | 517.29 | 478.81 | -497.04 | -783.36 | Upgrade
|
| Other Operating Activities | 8,123 | 10,174 | 14,103 | 15,731 | 10,883 | 18,652 | Upgrade
|
| Change in Accounts Receivable | 4,790 | -12,401 | -22,482 | 15,134 | -14,988 | 9,672 | Upgrade
|
| Change in Inventory | -849.96 | -33,422 | -33,194 | -16,568 | 15,153 | -31,272 | Upgrade
|
| Change in Accounts Payable | -14,637 | -1,309 | -7,213 | 20,501 | -2,987 | -2,950 | Upgrade
|
| Change in Unearned Revenue | 118.18 | 19.34 | -40.2 | 0.4 | 58.4 | 130.45 | Upgrade
|
| Change in Other Net Operating Assets | 9,883 | -4,141 | -6,273 | -12,848 | -1,134 | -19,935 | Upgrade
|
| Operating Cash Flow | 28,127 | -12,153 | -11,730 | 62,822 | 54,940 | 22,829 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 14.35% | 140.66% | -22.05% | Upgrade
|
| Capital Expenditures | -77,975 | -75,730 | -34,785 | -25,383 | -23,795 | -5,262 | Upgrade
|
| Sale of Property, Plant & Equipment | 6,418 | 5,483 | 4,050 | 306.46 | 263.45 | 1,468 | Upgrade
|
| Divestitures | 203.49 | - | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1,895 | -1,937 | -331.65 | -616.83 | -651.85 | -40.81 | Upgrade
|
| Investment in Securities | 77,851 | 86,121 | -14,583 | -17,896 | -18,993 | -67,062 | Upgrade
|
| Other Investing Activities | 5,935 | -2,395 | -26,295 | 200.59 | 443.5 | 23,377 | Upgrade
|
| Investing Cash Flow | 12,219 | 12,772 | -71,831 | -42,747 | -42,976 | -47,560 | Upgrade
|
| Short-Term Debt Issued | - | 568,500 | 264,000 | 119,000 | 116,000 | 106,500 | Upgrade
|
| Long-Term Debt Issued | - | 49,888 | 10,000 | - | 22,000 | - | Upgrade
|
| Total Debt Issued | 497,388 | 618,388 | 274,000 | 119,000 | 138,000 | 106,500 | Upgrade
|
| Short-Term Debt Repaid | - | -549,605 | -205,000 | -99,000 | -106,000 | -98,500 | Upgrade
|
| Long-Term Debt Repaid | - | -25,093 | -1,657 | -16,510 | -11,913 | -10,521 | Upgrade
|
| Total Debt Repaid | -469,948 | -574,698 | -206,657 | -115,510 | -117,913 | -109,021 | Upgrade
|
| Net Debt Issued (Repaid) | 27,440 | 43,690 | 67,343 | 3,490 | 20,087 | -2,521 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 9,525 | Upgrade
|
| Repurchase of Common Stock | -4,432 | -4,067 | -6,235 | - | - | - | Upgrade
|
| Dividends Paid | -4,008 | -4,008 | -4,108 | -4,108 | -4,108 | -3,166 | Upgrade
|
| Other Financing Activities | 1,150 | 1,150 | 1,010 | -10.5 | -85.54 | - | Upgrade
|
| Financing Cash Flow | 20,150 | 36,765 | 58,010 | -628.26 | 15,894 | 3,838 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2,477 | 1,461 | -657 | 139.36 | 1,226 | -504.97 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | 0 | -0 | 0 | - | Upgrade
|
| Net Cash Flow | 62,974 | 38,845 | -26,208 | 19,587 | 29,084 | -21,399 | Upgrade
|
| Free Cash Flow | -49,848 | -87,883 | -46,515 | 37,439 | 31,145 | 17,566 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 20.21% | 77.30% | 5.52% | Upgrade
|
| Free Cash Flow Margin | -3.10% | -5.36% | -3.07% | 2.61% | 2.33% | 1.41% | Upgrade
|
| Free Cash Flow Per Share | -1250.34 | -2195.59 | -1149.35 | 911.36 | 757.27 | 433.44 | Upgrade
|
| Cash Interest Paid | 11,650 | 11,651 | 7,506 | 3,748 | 2,369 | 2,532 | Upgrade
|
| Cash Income Tax Paid | 10,041 | 13,598 | 10,366 | 13,692 | 11,370 | 14,181 | Upgrade
|
| Levered Free Cash Flow | -87,889 | -139,015 | -58,701 | 35,407 | 59,535 | -17,775 | Upgrade
|
| Unlevered Free Cash Flow | -81,274 | -132,594 | -54,386 | 37,741 | 61,125 | -16,188 | Upgrade
|
| Change in Net Working Capital | 26,530 | 88,270 | 58,467 | -25,821 | -43,365 | 59,837 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.